703 filings
Page 8 of 36
8-K
lg5l9zc9u5h6 h7d
7 May 18
CytRx Corporation Names Eric L. Curtis
5:24pm
EFFECT
2aq26no
2 Apr 18
Notice of effectiveness
12:00am
424B3
cd95l9xfe76 rr9ik1sr
2 Apr 18
Prospectus supplement
12:00am
CORRESP
ch39z
27 Mar 18
Correspondence with SEC
12:00am
UPLOAD
vldttvaueol oaxmic9l
27 Mar 18
Letter from SEC
12:00am
8-K
uhh5xt1z8o
22 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
6k9xzmu6 dk5da
19 Mar 18
CytRx Reports 2017 Financial Results
12:00am
8-K
0nw4kzrn
1 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
ggvlxu8
9 Nov 17
CytRx Reports Third Quarter 2017 Financial Results
12:00am
8-K
nikyw5l z08dkbsm
8 Nov 17
CytRx Announces Strategic Realignment of Clinical Development Team
12:00am
8-K
87pksh
1 Nov 17
CytRx Corporation Announces Results from Special Meeting of Stockholders
12:00am
8-K
dug20
19 Oct 17
CytRx Corporation Announces Outcome of Nasdaq Hearing
12:00am
8-K
v4t jij20l
5 Oct 17
Other Events
12:00am
8-K
jr9j advd
21 Sep 17
Other Events
12:00am
CT ORDER
mmi53 s560l
15 Sep 17
Confidential treatment order
12:00am
DEFA14A
5dmzpru2
13 Sep 17
Additional proxy soliciting materials
12:00am
8-K
bv08i0l
13 Sep 17
CytRx Corporation Announces Amendment to Definitive Proxy Statement for Upcoming Special Meeting
12:00am